Synthesis and amyloid binding properties of rhenium complexes

Preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain

Weiguo Zhen, Hogyu Han, Magdalena Anguiano, Cynthia A. Lemere, Cheon G. Cho, Peter T. Lansbury

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The definitive diagnosis of Alzheimer's disease (AD) requires the detection of amyloid plaques in postmortem brain. Although the amount of fibrillar amyloid roughly correlates with the severity of symptoms at the time of death, the temporal relationship between amyloid deposition, neuronal loss, and cognitive decline is unclear. To elucidate this relationship, a noninvasive, practical method for the quantitation of brain amyloid deposition is required. We describe herein the initial stages of a strategy to accomplish this goal by single photon computed tomographic imaging. The amyloid-binding dye Congo Red was modified to allow its conjugation to the monoamine-monoamide bis(thiol) ligand. This ligand complexes technetium(V) in its neutral oxo form. A biphenyl-containing building block was conjugated to the protected ligand, and the product was coupled to the relevant aromatic compounds. Rhenium oxo complexes, which are isosteric, but nonradioactive, analogues of the potential imaging agent technetium oxo complexes, were synthesized. These complexes bound to Aβ amyloid fibrils produced in vitro and stained amyloid plaques and vascular amyloid in AD brain sections.

Original languageEnglish
Pages (from-to)2805-2815
Number of pages11
JournalJournal of Medicinal Chemistry
Volume42
Issue number15
DOIs
Publication statusPublished - 1999 Jul 29

Fingerprint

Rhenium
Single-Photon Emission-Computed Tomography
Amyloid
Brain
Alzheimer Disease
Imaging techniques
Technetium
Amyloid Plaques
Ligands
Congo Red
Photons
Sulfhydryl Compounds
Blood Vessels
Aromatic compounds
Coloring Agents

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Synthesis and amyloid binding properties of rhenium complexes : Preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain. / Zhen, Weiguo; Han, Hogyu; Anguiano, Magdalena; Lemere, Cynthia A.; Cho, Cheon G.; Lansbury, Peter T.

In: Journal of Medicinal Chemistry, Vol. 42, No. 15, 29.07.1999, p. 2805-2815.

Research output: Contribution to journalArticle

Zhen, Weiguo ; Han, Hogyu ; Anguiano, Magdalena ; Lemere, Cynthia A. ; Cho, Cheon G. ; Lansbury, Peter T. / Synthesis and amyloid binding properties of rhenium complexes : Preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain. In: Journal of Medicinal Chemistry. 1999 ; Vol. 42, No. 15. pp. 2805-2815.
@article{03a374f8d36d4aff958a55c5678628db,
title = "Synthesis and amyloid binding properties of rhenium complexes: Preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain",
abstract = "The definitive diagnosis of Alzheimer's disease (AD) requires the detection of amyloid plaques in postmortem brain. Although the amount of fibrillar amyloid roughly correlates with the severity of symptoms at the time of death, the temporal relationship between amyloid deposition, neuronal loss, and cognitive decline is unclear. To elucidate this relationship, a noninvasive, practical method for the quantitation of brain amyloid deposition is required. We describe herein the initial stages of a strategy to accomplish this goal by single photon computed tomographic imaging. The amyloid-binding dye Congo Red was modified to allow its conjugation to the monoamine-monoamide bis(thiol) ligand. This ligand complexes technetium(V) in its neutral oxo form. A biphenyl-containing building block was conjugated to the protected ligand, and the product was coupled to the relevant aromatic compounds. Rhenium oxo complexes, which are isosteric, but nonradioactive, analogues of the potential imaging agent technetium oxo complexes, were synthesized. These complexes bound to Aβ amyloid fibrils produced in vitro and stained amyloid plaques and vascular amyloid in AD brain sections.",
author = "Weiguo Zhen and Hogyu Han and Magdalena Anguiano and Lemere, {Cynthia A.} and Cho, {Cheon G.} and Lansbury, {Peter T.}",
year = "1999",
month = "7",
day = "29",
doi = "10.1021/jm990103w",
language = "English",
volume = "42",
pages = "2805--2815",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "15",

}

TY - JOUR

T1 - Synthesis and amyloid binding properties of rhenium complexes

T2 - Preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain

AU - Zhen, Weiguo

AU - Han, Hogyu

AU - Anguiano, Magdalena

AU - Lemere, Cynthia A.

AU - Cho, Cheon G.

AU - Lansbury, Peter T.

PY - 1999/7/29

Y1 - 1999/7/29

N2 - The definitive diagnosis of Alzheimer's disease (AD) requires the detection of amyloid plaques in postmortem brain. Although the amount of fibrillar amyloid roughly correlates with the severity of symptoms at the time of death, the temporal relationship between amyloid deposition, neuronal loss, and cognitive decline is unclear. To elucidate this relationship, a noninvasive, practical method for the quantitation of brain amyloid deposition is required. We describe herein the initial stages of a strategy to accomplish this goal by single photon computed tomographic imaging. The amyloid-binding dye Congo Red was modified to allow its conjugation to the monoamine-monoamide bis(thiol) ligand. This ligand complexes technetium(V) in its neutral oxo form. A biphenyl-containing building block was conjugated to the protected ligand, and the product was coupled to the relevant aromatic compounds. Rhenium oxo complexes, which are isosteric, but nonradioactive, analogues of the potential imaging agent technetium oxo complexes, were synthesized. These complexes bound to Aβ amyloid fibrils produced in vitro and stained amyloid plaques and vascular amyloid in AD brain sections.

AB - The definitive diagnosis of Alzheimer's disease (AD) requires the detection of amyloid plaques in postmortem brain. Although the amount of fibrillar amyloid roughly correlates with the severity of symptoms at the time of death, the temporal relationship between amyloid deposition, neuronal loss, and cognitive decline is unclear. To elucidate this relationship, a noninvasive, practical method for the quantitation of brain amyloid deposition is required. We describe herein the initial stages of a strategy to accomplish this goal by single photon computed tomographic imaging. The amyloid-binding dye Congo Red was modified to allow its conjugation to the monoamine-monoamide bis(thiol) ligand. This ligand complexes technetium(V) in its neutral oxo form. A biphenyl-containing building block was conjugated to the protected ligand, and the product was coupled to the relevant aromatic compounds. Rhenium oxo complexes, which are isosteric, but nonradioactive, analogues of the potential imaging agent technetium oxo complexes, were synthesized. These complexes bound to Aβ amyloid fibrils produced in vitro and stained amyloid plaques and vascular amyloid in AD brain sections.

UR - http://www.scopus.com/inward/record.url?scp=0033614955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033614955&partnerID=8YFLogxK

U2 - 10.1021/jm990103w

DO - 10.1021/jm990103w

M3 - Article

VL - 42

SP - 2805

EP - 2815

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 15

ER -